Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Scorpion Therapeutics (United States) | Researchclopedia

Back to institutions

Scorpion Therapeutics (United States)

Boston, Massachusettscompany

36

Works

2,520

Citations

29

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Advanced Breast Cancer Therapies Melanoma and MAPK Pathways

Top Researchers

Gregory V. Kryukov Q Therapeutics (United States)

198 works47,740 citationsh-index: 56

Recent Research

Developments and Activities in FMODB up to 2025: A Release Note

Chiduru Watanabe,Kikuko Kamisaka,et al.

20250 citations

Cancer therapeutics and mechanisms

Multiple Sclerosis Research Studies

Protein Kinase Regulation and GTPase Signaling

Computational Drug Discovery Methods

Neurogenesis and neuroplasticity mechanisms

Amyotrophic Lateral Sclerosis Research

PI3K/AKT/mTOR signaling in cancer

Click Chemistry and Applications

Lung Cancer Diagnosis and Treatment

Axel Hoos GlaxoSmithKline (United States)

318 works42,026 citationsh-index: 67

159 works14,560 citationsh-index: 37

Philip Jonsson Celsius Therapeutics (United States)

193 works13,593 citationsh-index: 41

Erica L. Jackson

128 works9,054 citationsh-index: 25

Angel Guzmán-Pérez Scorpion Therapeutics (United States)

78 works5,844 citationsh-index: 32

P3.18.68 First-In-Human Trial of PFL-241/STX-241 in Patients With Locally Advanced or Metastatic NSCLC Resistant to EGFR Tyrosine Kinase Inhibitors

Gerrina Ruiter,M.L. Johnson,et al.

20250 citations

Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in <i>KEAP1</i> -Mutant Lung Cancer

Melat T. Gebru,Timothy E. Hoffman,et al.

20251 citations

STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models

Raymond A. Pagliarini,Jack A. Henderson,et al.

20254 citations

Trial in progress: First-in-human study of PFL-721/STX-721 in participants with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20 insertion mutations.

Anas Gazzah,Chia‐Chi Lin,et al.

20250 citations

Discovery of STX-721, a Covalent, Potent, and Highly Mutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatment of Non-Small Cell Lung Cancer

Benjamin C. Milgram,Deanna R. Borrelli,et al.

20254 citations